FDAInternational Bladder Cancer GroupNCTFDA-approved
…n launched and their outcomes are awaited. As of June 2025, the FDA has approved valrubicin, pembrolizumab, nadofaragene firadenove…
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: International Consensus Panel ×
International Consensus Panel
This institution is selected. Its supporting articles are shown below.